Related Experiment Video
Updated: Feb 14, 2026

Protocol for Isolating the Mouse Circle of Willis
Published on: October 22, 2016
Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk
Griselda Vallès-Cardona1, Assumpta Caixàs2, Irene Berges2
1Pediatric Department, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí I3PT-CERCA, Universitat Autónoma de Barcelona, Sabadell, Spain.
Individuals with Prader-Willi syndrome (PWS) exhibit a unique hypercoagulable state, independent of obesity. This finding suggests a need for tailored thrombotic risk assessment and preventative strategies in PWS patients.
Area of Science:
- Endocrinology
- Hematology
- Genetics
Background:
- Prader-Willi syndrome (PWS) is linked to severe obesity and endocrine issues, increasing cardiovascular risks.
- A higher incidence of thromboembolic events in PWS suggests a potential intrinsic hypercoagulable state.
Purpose of the Study:
- To investigate the hemostatic profile in Prader-Willi syndrome patients.
- To determine if PWS is associated with a hypercoagulable state independent of obesity.
Main Methods:
- A case-control study involving 49 PWS patients (pediatric and adult) and 85 matched controls.
- Comprehensive hemostatic assessment including coagulation tests, thrombophilia screening, factor VIII, von Willebrand factor (vWF:Ag), platelet function analysis (PFA), thrombin generation test (TGT), and thromboelastography (TEG).
Main Results:
- Standard coagulation and thrombophilia tests were mostly normal.
- Elevated D-dimer and vWF:Ag levels were observed in PWS patients, unrelated to obesity or inflammation.
- Thromboelastography revealed a hypercoagulable pattern in nearly 90% of PWS participants, irrespective of BMI or metabolic status.
Conclusions:
- PWS is associated with a distinct hypercoagulable profile, likely due to endothelial dysfunction rather than typical thrombophilia.
- This hypercoagulable state in PWS is not solely explained by obesity.
- Personalized thrombotic risk assessment and preventive strategies are warranted for PWS individuals.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Acute Coronary Syndrome III: Diagnostic Studies
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

